Antimicrobial resistance in developing countries. Part II: Strategies for containment

Lancet Infectious Diseases

Volumn 5, Issue 9, 2005, Pages 568-580

  Okeke, Iruka N ^a   Klugman, Keith P ^b,c,d   Bhutta, Zulfiqar A ^e   Duse, Adriano G ^f   Jenkins, Philip ^g   O'Brien, Thomas F ^h   Pablos Mendez, Ariel ⁱ   Laxminarayan, Ramanan ^j  

^a HAVERFORD COLLEGE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c EMORY UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e AGA KHAN UNIVERSITY   (Pakistan)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ ROCKEFELLER FOUNDATION   (United States)

^j RESOURCES FOR THE FUTURE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ARTESUNATE; CEPHALOSPORIN; CHLOROQUINE; COTRIMOXAZOLE; FANSIDAR; MEFLOQUINE; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CONTINUING EDUCATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CROSS RESISTANCE; DEVELOPED COUNTRY; DISEASE TRANSMISSION; DRUG DISTRIBUTION; DRUG MISUSE; DRUG USE; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFECTION; INFECTION CONTROL; INFECTION RISK; LABORATORY TEST; MALARIA; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SELF MEDICATION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES, EMERGING; DEVELOPING COUNTRIES; DRUG AND NARCOTIC CONTROL; DRUG RESISTANCE, BACTERIAL; HUMANS; INTERNATIONAL COOPERATION; POPULATION SURVEILLANCE; RISK FACTORS; WORLD HEALTH;

EID: 23944500827     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70217-6     Document Type: Review

References (181)

1. J Acar, E Kaplan, TE O'Brien Monitoring and management of bacterial resistance to antibmicrobial agents: a World Health Organization Symposium, Geneva, Switzerland, 29th November-2nd December, 1994 Clin Infect Dis 24 suppl 1 1997 S1 176
2. LJ Martin, M Fyfe, K Dore Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections J Infect Dis 189 2004 377 384
3. IN Okeke, R Laxminarayan, Z Bhutta Antimicrobial resistance in developing countries. Part I: recent trends and current status Lancet Infect Dis 5 2005 481 493
4. R Smith, J Coast, M Millar, P Wilton, AM Karcher Interventions against antimicrobial resistance 2001 Global Forum for Health Research Geneva
5. A Radyowijati, H Haak Improving antibiotic use in low-income countries: an overview of evidence on determinants Soc Sci Med 57 2003 733 744
6. H Bauchner, S Osganian, K Smith, R Triant Improving parent knowledge about antibiotics: a video intervention Pediatrics 108 2001 845 850
7. TW Hennessy, KM Petersen, D Bruden Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska Clin Infect Dis 34 2002 1543 1550
8. VA Arason, A Gunnlaugsson, JA Sigurdsson, H Erlendsdottir, S Gudmundsson, KG Kristinsson Clonal spread of resistant pneumococci despite diminished antimicrobial use Microb Drug Resist 8 2002 187 192
9. SB Levy Antibiotic resistance: consequences of inaction Clin Infect Dis 33 suppl 3 2001 S124 S129
10. DR Feikin, SF Dowell, OC Nwanyanwu Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine J Infect Dis 181 2000 1501 1505
11. SA Madhi, C Cutland, K Ismail, C O'Reilly, A Mancha, KP Klugman Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia Clin Infect Dis 35 2002 1120 1126
12. AG Duse Antibiotic resistance in developing countries A Emmerson M Arrowsmith Infection control practices 1998 3M Medical Markets Laboratory Borken, Germany 38 44
13. MB Zaidi, E Zamora, P Diaz, L Tollefson, PJ Fedorka-Cray, ML Headrick Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children Antimicrob Agents Chemother 47 2003 1999 2001
14. MH Samore, MK Magill, SC Alder High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission Pediatrics 108 2001 856 865
15. SI Pelton, AM Loughlin, CD Marchant Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates Pediatr Infect Dis J 23 2004 1015 1022
16. WHO WHO global strategy for containment of antibiotic resistance 2001 WHO Geneva 99
17. WHO Implementation workshop on the WHO global strategy for containment of antimicrobial resistance 2002 WHO Geneva
18. KA Holloway Prioritsing interventions to contain antimicrobial resistance Essential Drugs Monitor 2000 16 18
19. R Laxminarayan, Z Bhutta, A Duse Drug resistance D Jamison D Evans G Alleyne Disease control priorities in developing countries 2005 WHO and Fogarty International Center, NIH Washington DC
20. F Nosten, M van Vugt, R Price Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302
21. JG Kublin, JF Cortese, EM Njunju Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi J Infect Dis 187 2003 1870 1875
22. S Bonhoeffer, M Lipsitch, BR Levin Evaluating treatment protocols to prevent antibiotic resistance Proc Natl Acad Sci USA 94 1997 12106 12111
23. R Laxminarayan, ML Weitzman On the implications of endogenous resistance to medications J Health Econ 21 2002 709 718
24. VN Balasubramanian, K Oommen, R Samuel DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India Int J Tuberc Lung Dis 4 2000 409 413
25. C Dye, BG Williams, MA Espinal, MC Raviglione Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis Science 295 2002 2042 2046
26. E Gouws, J Bryce, JP Habicht Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy Bull World Health Organ 82 2004 509 515
27. RD Wammanda, CL Ejembi, T Iorliam Drug treatment costs: projected impact of using the integrated management of childhood illnesses Trop Doct 33 2003 86 88
28. A Bexell, E Lwando, B von Hofsten, S Tembo, B Eriksson, VK Diwan Improving drug use through continuing education: a randomized controlled trial in Zambia J Clin Epidemiol 49 1996 355 357
29. B Santoso, S Suryawati, JE Prawaitasari Small group intervention vs formal seminar for improving appropriate drug use Soc Sci Med 42 1996 1163 1168
30. IA Agyepong, E Ansah, M Gyapong, S Adjei, G Barnish, D Evans Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana Soc Sci Med 55 2002 2215 2226
31. L Qingjun, D Jihui, T Laiyi The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China Bull World Health Organ 76 suppl 1 1998 21 27
32. DL Helitzer-Allen, DA McFarland, JJ Wirima, AP Macheso Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions Soc Sci Med 36 1993 403 407
33. P Paredes, M de la Pena, E Flores-Guerra, J Diaz, J Trostle Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue Soc Sci Med 42 1996 1141 1153
34. I Kurlat, G Corral, F Oliveira, G Farinella, E Alvarez Infection control strategies in a neonatal intensive care unit in Argentina J Hosp Infect 40 1998 149 154
35. KP Klugman Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance Lancet Infect Dis 1 2001 85 91
36. CG Whitney, MM Farley, J Hadler Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 2003 1737 1746
37. RE Huebner, AD Wasas, KP Klugman Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998 Int J Infect Dis 4 2000 214 218
38. DR Feikin, M Davis, OC Nwanyanwu Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children Pediatr Infect Dis J 22 2003 564 567
39. GM Zhao, S Black, H Shinefield Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China Pediatr Infect Dis J 22 2003 739 742
40. SK Saha, AH Baqui, GL Darmstadt Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation J Clin Microbiol 41 2003 5582 5587
41. ME Birmingham, LA Lee, M Ntakibirora, F Bizimana, MS Deming A household survey of dysentery in Burundi: implications for the current pandemic in sub-Saharan Africa Bull World Health Organ 75 1997 45 53
42. V Curtis, S Cairncross Effect of washing hands with soap on diarrhoea risk in the community: a systematic review Lancet Infect Dis 3 2003 275 281
43. WH Oddy The impact of breastmilk on infant and child health Breastfeed Rev 10 2002 5 18
44. M Khann, R Celik Cost of nosocomial infection in Turkey: an estimate based on universal hospital data Health Services Management Research 14 2001 49 54
45. J Coast, R Smith, AM Karcher, P Wilton, M Millar Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance? Health Econ 11 2002 637 647
46. JM Wilson, GN Chandler Sustained improvements in hygiene behaviour amongst village women in Lombok, Indonesia Trans R Soc Trop Med Hyg 87 1993 615 616
47. BA Lipsky, CA Baker, LL McDonald, NT Suzuki Improving the appropriateness of vancomycin use by sequential interventions Am J Infect Control 27 1999 84 91
48. A Perez, RJ Dennis, B Rodriguez An interrupted time series analysis of parenteral antibiotic use in Colombia J Clin Epidemiol 56 2003 1013 1020
49. TP de Vries, RH Henning, HV Hogerzeil Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study Lancet 346 1995 1454 1457
50. TI Bhutta, A Vitry Treating dysentery with metronidazole in Pakistan BMJ 314 1997 146 147
51. JE Hadiyono, S Suryawati, SS Danu, Sunartono, B Santoso Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities Soc Sci Med 42 1996 1177 1183
52. WHO Interventions and strategies to improve the use of antimicrobials in developing countries 2001 WHO Geneva
53. G Gutierrez, H Guiscafre, M Bronfman, J Walsh, H Martinez, O Munoz Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City Med Care 32 1994 436 446
54. R Perez-Cuevas, H Guiscafre, O Munoz Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico Soc Sci Med 42 1996 1185 1194
55. V Thamlikitkul, S Danchaivijitr, S Kongpattanakul, S Ckokloikaew Impact of an educational program on antibiotic use in a tertiary care hospital in a developing country J Clin Epidemiol 51 1998 773 778
56. NT Chuc, M Larsson, NT Do, VK Diwan, GB Tomson, T Falkenberg Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam J Clin Epidemiol 55 2002 1148 1155
57. JC Meyer, RS Summers, H Moller Randomized, controlled trial of prescribing training in a South African province Med Educ 35 2001 833 840
58. S Chakraborty, SA D'Souza, RS Northrup Improving private practitioner care of sick children: testing new approaches in rural Bihar Health Policy Plan 15 2000 400 407
59. H Hogerzeil, R Laing, D Ross-Degnan Ten recommendations to promote use of medicines in developing countries 1999 WHO Geneva 3 12
60. D Ofori-Adjei, DK Arhinful Effect of training on the clinical management of malaria by medical assistants in Ghana Soc Sci Med 42 1996 1169 1176
61. A Le Grand, HV Hogerzeil, FM Haaijer-Ruskamp Intervention research in rational use of drugs: a review Health Policy Plan 14 1999 89 102
62. O Ande, O Oladepo, WR Brieger Comparison of knowledge on diarrheal disease management between two types of community-based distributors in Oyo State, Nigeria Health Educ Res 19 2004 110 113
63. A Djimde, CV Plowe, S Diop, A Dicko, TE Wellems, O Doumbo Use of antimalarial drugs in Mali: policy versus reality Am J Trop Med Hyg 59 1998 376 379
64. PJ Garcia, KK Holmes STD trends and patterns of treatment for STD by physicians in private practice in Peru Sex Transm Infect 79 2003 403 407
65. AA Indalo Antibiotic sale behaviour in Nairobi: a contributing factor to antimicrobial drug resistance East Afr Med J 74 1997 171 173
66. M Lansang, R Lucas-Aquino, T Tupasi Purchase of antibiotics without prescription on Manila, the Phillipines J Clin Epidemiol 43 1990 61 67
67. UA Igun Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria Soc Sci Med 39 1994 797 806
68. AY Massele, J Sayi, SE Nsimba, D Ofori-Adjei, RO Laing Knowledge and management of malaria in Dar es Salaam, Tanzania East Afr Med J 70 1993 639 642
69. M Larsson, G Kronvall, NT Chuc Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community Trop Med Int Health 5 2000 711 721
70. R Uppal, U Sarkar, CS Giriyappanavar, V Kacker Pharmacoepidemiology of drug use at two primary health care centres in northern India Int J Clin Pharmacol Ther 32 1994 284 285
71. V Dua, CM Kunin, LV White The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country Soc Sci Med 38 1994 717 724
72. A Bartoloni, F Cutts, S Leoni Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia Trop Med Int Health 3 1998 116 123
73. J Chalker, NT Chuc, T Falkenberg, G Tomson Private pharmacies in Hanoi, Vietnam: a randomized trial of a 2-year multi-component intervention on knowledge and stated practice regarding ARI, STD and antibiotic/steroid requests Trop Med Int Health 7 2002 803 810
74. D Ross-Degnan, SB Soumerai, PK Goel The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies Health Policy Plan 11 1996 308 318
75. EJ Adams, PJ Garcia, GP Garnett, WJ Edmunds, KK Holmes The cost-effectiveness of syndromic management in pharmacies in Lima, Peru Sex Transm Dis 30 2003 379 387
76. CM Kunin Problems in antibiotic usage G Mandel R Douglas J Bennett Mandell, Douglas, and Bennett's principles and practice of infectious diseases 3rd edn. 1990 Churchill Livingstone Edinburgh 427 433
77. CJ Kubin Antimicrobial control programs Semin Perinatol 26 2002 379 386
78. A Erbay, A Colpan, H Bodur, MA Cevik, MH Samore, O Ergonul Evaluation of antibiotic use in a hospital with an antibiotic restriction policy Int J Antimicrob Agents 21 2003 308 312
79. X Saez-Llorens, MM Castrejon de Wong, E Castano, O De Suman, D De Moros, I De Atencio Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country Pediatr Infect Dis J 19 2000 200 206
80. S Gove Integrated management of childhood illness by outpatient health workers: technical basis and overview. The WHO working group on guidelines for integrated management of the sick child Bull World Health Organ 75 suppl 1 1997 7 24
81. PA Phillips-Howard, KA Wannemuehler, FO ter Kuile Diagnostic and prescribing practices in peripheral health facilities in rural western Kenya Am J Trop Med Hyg 68 suppl 4 2003 44 49
82. D Oluwole, E Mason, A Costello Management of childhood illness in Africa. Early evaluations show promising results BMJ 320 2000 594 595
83. MM Khan, KK Saha, S Ahmed Adopting integrated management of childhood illness module at local level in Bangladesh: implications for recurrent costs J Health Popul Nutr 20 2002 42 50
84. LL Boulanger, LA Lee, A Odhacha Treatment in Kenyan rural health facilities: projected drug costs using the WHO-UNICEF integrated management of childhood illness (IMCI) guidelines Bull World Health Organ 77 1999 852 858
85. J Armstrong Schellenberg, J Bryce, D de Savigny The effect of Integrated Management of Childhood Illness on observed quality of care of under-fives in rural Tanzania Health Policy Plan 19 2004 1 10
86. R Laing, H Hogerzeil, D Ross-Degnan Ten recommendations to improve use of medicines in developing countries Health Policy Plan 16 2001 13 20
87. P Ball, F Baquero, O Cars Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence J Antimicrob Chemother 49 2002 31 40
88. CK Lan, PR Hsueh, WW Wong Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase- producing organisms J Microbiol Immunol Infect 36 2003 182 186
89. J Garau Have guidelines had an impact on antimicrobial resistance? Semin Respir Infect 16 2001 210 214
90. V Thamlikitkul, W Apisitwittaya Implementation of clinical practice guidelines for upper respiratory infection in Thailand Int J Infect Dis 8 2004 47 51
91. II Angunawela, VK Diwan, G Tomson Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri Lanka Int J Epidemiol 20 1991 558 564
92. F Fasehun The antibacterial paradox: essential drugs, effectiveness, and cost Bull World Health Organ 77 1999 211 216
93. WHO The selection and use of essential medicines. Report of the WHO expert committee 2002 WHO Geneva
94. B Lindtjorn Essential drug list in a rural hospital. Does it have any influence on drug prescription? Trop Doct 17 1987 151 155
95. AF Mabadeje, AA Akintonwa, RB Ashorobi The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital Clin Pharmacol Ther 50 1991 121 124
96. JC Pechere Patients' interviews and misuse of antibiotics Clin Infect Dis 33 suppl 3 2001 S170 S173
97. BJ Goff, JM Koff, JA Geiling Obtaining antibiotics without a prescription N Engl J Med 347 2002 223
98. B Carey, B Cryan Antibiotic misuse in the community - a contributor to resistance? Ir Med J 96 2003 43 44 46
99. DJ Edwards, PB Richman, K Bradley, B Eskin, M Mandell Parental use and misuse of antibiotics: are there differences in urban vs. suburban settings? Acad Emerg Med 9 2002 22 26
100. H Reyes, H Guiscafre, O Munoz, R Perez-Cuevas, H Martinez, G Gutierrez Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea J Clin Epidemiol 50 1997 1297 1304
101. A Guyon, A Barman, J Ahmed, A Ahmed, M Alam A baseline survey on the use of drugs at the primary health care level in Bangladesh Bull World Health Organ 72 1994 265 271
102. U Dutta, NM Gupta, B Nagi, K Singh Blister pack ingestion resulting in esophago-pleural fistula Indian J Gastroenterol 20 2001 79 80
103. G Kansal, V Agrawal Intestinal perforation - a unique cause J Indian Med Assoc 98 2000 184 186
104. LW Yip, FS Goh, RS Sim "I've got a UFO stuck in my throat!" - an interesting case of foreign body impaction in the oesophagus Singapore Med J 39 1998 121 123
105. FK Chan, JJ Sung, PY Tam, KH Kwong, JW Lau "Blister pack"-induced gastrointestinal hemorrhage Am J Gastroenterol 92 1997 172 173
106. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN) Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India Lancet 353 1999 1216 1221
107. BL Davidson A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States Chest 114 1998 1239 1243
108. C Dye, CJ Watt, D Bleed Low access to a highly effective therapy: a challenge for international tuberculosis control Bull World Health Organ 80 2002 437 444
109. K Floyd, D Wilkinson, C Gilks Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa BMJ 315 1997 1407 1411
110. Q Xu, SG Jin, LX Zhang Cost effectiveness of DOTS and non-DOTS strategies for smear-positive pulmonary tuberculosis in Beijing Biomed Environ Sci 13 2000 307 313
111. GR Khatri, TR Frieden Rapid DOTS expansion in India Bull World Health Organ 80 2002 457 463
112. WHO Global tuberculosis control-surveillance, planning, financing 2004 WHO Geneva
113. D Wilkinson, GR Davies Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Directly observed therapy Trop Med Int Health 2 1997 700 704
114. RD Barker, FJ Millard, ME Nthangeni Unpaid community volunteers-effective providers of directly observed therapy (DOT) in rural South Africa S Afr Med J 92 2002 291 294
115. P Pungrassami, V Chongsuvivatwong Are health personnel the best choice for directly observed treatment in southern Thailand? A comparison of treatment outcomes among different types of observers Trans R Soc Trop Med Hyg 96 2002 695 699
116. JE Olle-Goig, J Alvarez Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of H pital Albert Schweitzer Int J Tuberc Lung Dis 5 2001 137 141
117. WHO RE Gupta, TE Arnadottir Guidelines for Establishing DOTS-PLUS Pilot Projects for the Management of MDR-TB 2001 WHO Geneva
118. T Arnadottir Tuberculosis: trends and the twenty-first century Scand J Infect Dis 33 2001 563 567
119. K DeRiemer, L Garcia-Garcia, M Bobadilla-del-Valle Does DOTS work in populations with drug-resistant tuberculosis? Lancet 365 2005 1239 1245
120. G Friedland, S Abdool Karim, Q Abdool Karim Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries Clin Infect Dis 38 suppl 5 2004 S421 S428
121. C Wayland The failure of pharmaceuticals and the power of plants: medicinal discourse as a critique of modernity in the Amazon Soc Sci Med 58 2004 2409 2419
122. S Harbarth, AV Gundlapalli, W Stockdale, MH Samore Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre Int J Antimicrob Agents 21 2003 484 487
123. R Gupta, JY Kim, MA Espinal Public health. Responding to market failures in tuberculosis control Science 293 2001 1049 1051
124. R Gupta, A Irwin, MC Raviglione, JY Kim Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis Lancet 363 2004 320 324
125. IN Okeke, A Lamikanra, R Edelman Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries Emerg Infect Dis 5 1999 18 27
126. LA Salako, WR Brieger, BM Afolabi Treatment of childhood fevers and other illnesses in three rural Nigerian communities J Trop Pediatr 47 2001 230 238
127. WR Brieger, PE Osamor, KK Salami, O Oladepo, SA Otusanya Interactions between patent medicine vendors and customers in urban and rural Nigeria Health Policy Plan 19 2004 177 182
128. J Primo-Carpenter A review of drug quality in Asia with focus on anti-infectives 2004 United States Pharmacopeial Convention, Inc Washington DC 50
129. SQ Nizami, IA Khan, ZA Bhutta Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan Soc Sci Med 42 1996 1133 1139
130. R Bojalil, JJ Calva Antibiotic misuse in diarrhea. A household survey in a Mexican community J Clin Epidemiol 47 1994 147 156
131. S O'Connor, D Rifkin, YH Yang, JF Wang, OS Levine, SF Dowell Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs Pediatr Infect Dis J 20 2001 679 684
132. NT Chuc, G Tomson "Doi moi" and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam Eur J Clin Pharmacol 55 1999 325 332
133. EK Mberu, MK Mosobo, AM Nzila, GO Kokwaro, CH Sibley, WM Watkins The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya Am J Trop Med Hyg 62 2000 396 401
134. DJ Terlouw, BL Nahlen, JM Courval Sulfadoxine-pyrimethamine in treatment of malaria in western Kenya: increasing resistance and underdosing Antimicrob Agents Chemother 47 2003 2929 2932
135. CH Sibley, JE Hyde, PF Sims Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17 2001 582 588
136. YC Liu, WK Huang, TS Huang, CM Kunin Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine Lancet 354 1999 1360
137. YC Liu, WK Huang, TS Huang, CM Kunin Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan Arch Intern Med 161 2001 2366 2370
138. N Parimi, LM Pinto Pereira, P Prabhakar The general public's perceptions and use of antimicrobials in Trinidad and Tobago Rev Panam Salud Publica 12 2002 11 18
139. IN Okeke, A Lamikanra Export of antimicrobial drugs by West African travelers J Travel Med 10 2003 133 135
140. P Bi, S Tong, KA Parton Family self-medication and antibiotics abuse for children and juveniles in a Chinese city Soc Sci Med 50 2000 1445 1450
141. F Crabbe, H Carsauw, A Buve, M Laga, JP Tchupo, A Trebucq Why do men with urethritis in Cameroon prefer to seek care in the informal health sector? Genitourin Med 72 1996 220 222
142. I Okeke Antibiotic use and resistance in developing countries S Knobler S Lemon M Najafi T Burroughs The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment-workshop summary 2003 Institute of Medicine, National Academy of Science Washington DC 132 139
143. G Marin, L Burhansstipanov, CM Connell A research agenda for health education among underserved populations Health Educ Q 22 1995 346 363
144. E Gonzalez Ochoa, L Armas Perez, JR Bravo Gonzalez, J Cabrales Escobar, R Rosales Corrales, G Abreu Suarez Prescription of antibiotics for mild acute respiratory infections in children Bull Pan Am Health Organ 30 1996 106 117
145. MB Denis Improving compliance with quinine + tetracycline for treatment of malaria: evaluation of health education interventions in Cambodian villages Bull World Health Organ 76 suppl 1 1998 43 49
146. L Bavestrello, A Cabello, D Casanova Impact of regulatory measures in the trends of community consumption of antibiotics in Chile Rev Med Chil 130 2002 1265 1272 (in Spanish)
147. TI Bhutta, C Balchin Assessing the impact of a regulatory intervention in Pakistan Soc Sci Med 42 1996 1195 1202
148. L Bavestrello, A Cabello How Chile tackled overuse of antimicrobials Essential Drugs Monitor 2000 13 14
149. AA Forder How best to utilize limited resources J Hosp Infect 30 suppl 1995 15 25
150. P Folb, M Dukes Pharmaceutical policies in sub-Saharan Africa. What more can be done? 1994 World Bank, Africa Technical Department, Population, Health and Nutrition Division
151. WHO Counterfeit drugs: A report of a joint WHO/IFMPA workshop 1992 WHO Geneva
152. E Wondemagegnehu Counterfeit and substandard drugs in Myanmar and Vietnam 1999 WHO Geneva
153. IN Okeke, A Lamikanra Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community Int J Antimicrob Agents 5 1995 245 250
154. O Shakoor, RB Taylor, RH Behrens Assessment of the incidence of substandard drugs in developing countries Trop Med Int Health 2 1997 839 845
155. RB Taylor, O Shakoor, RH Behrens Pharmacopoeial quality of drugs supplied by Nigerian pharmacies Lancet 357 2001 1933 1936
156. IN Okeke, A Lamikanra Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community Afr J Med Med Sci 30 2001 47 51
157. SC Arya Global response to antimicrobial resistance Bull World Health Organ 80 2002 420
158. SJ Schrag, C Pena, J Fernandez Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial JAMA 286 2001 49 56
159. JA Berkley, I Mwangi, CJ Ngetsa Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa Lancet 357 2001 1753 1757
160. HU Rashid, SA Chowdhury, N Islam Pattern of antibiotic use in two teaching hospitals Trop Doct 16 1986 152 154
161. VK Lim, YM Cheong Bacteriology turnaround time in seven Malaysian general hospitals Malays J Pathol 14 1992 41 43
162. RL Shapiro, L Kumar, P Phillips-Howard Antimicrobial-resistant bacterial diarrhea in rural western Kenya J Infect Dis 183 2001 1701 1704
163. DC Halstead, N Gomez, YS McCarter Reality of developing a community-wide antibiogram J Clin Microbiol 42 2004 1 6
164. RJ Williams, MJ Ryan Surveillance of antimicrobial resistance - an international perspective BMJ 317 1998 651 660
165. LN Mutanda, AM Omari, IA Wamola Adaptation of a method of measuring zone diameters of bacterial growth inhibition by antibiotics to suit developing countries East Afr Med J 66 1989 441 447
166. TF O'Brien, JM Stelling WHONET: removing obstacles to the full use of information about antibiotic resistance Diag Microbiol Infect Dis 25 1996 163 168
167. H Seppala, T Klaukka, J Vuopio-Varkila The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med 337 1997 441 446
168. FM Aarestrup, AM Seyfarth, HD Emborg, K Pedersen, RS Hendriksen, F Bager Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark Antimicrob Agents Chemother 45 2001 2054 2059
169. Holloway K, Sorensen T, WHO pilot projects to contain antimicrobial resistance. Second International Conference on Improving Use of Medicines; March 30-April 2, 2004; Chiang Mai, Thailand
170. VI Enne, DM Livermore, P Stephens, LM Hall Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction Lancet 357 2001 1325 1328
171. R Anderson, R May Infectious diseases of humans: dynamics and control 1991 Oxford University Press Oxford, New York
172. DQ Liu, RJ Liu, DX Ren Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China Bull World Health Organ 73 1995 483 486
173. JF Cortese, A Caraballo, CE Contreras, CV Plowe Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America J Infect Dis 186 2002 999 1006
174. J Tapsall Antimicrobial resistance in Neisseria gonorrheae 2001 Department of Communicable Disease Surveillance and Response, WHO Geneva, Switzerland
175. CT Bergstrom, M Lo, M Lipsitch Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals Proc Natl Acad Sci USA 101 2004 13285 13290
176. BR Levin, MJ Bonten Cycling antibiotics may not be good for your health Proc Natl Acad Sci USA 101 2004 13101 13102
177. SR Palumbi Humans as the world's greatest evolutionary force Science 293 2001 1786 1790
178. P Huovinen, L Sundström, G Swedberg, O Sköld Trimethoprim and sulfonamide resistance Antimicrob Agents Chemother 39 1995 279 289
179. P Wilton, R Smith, J Coast, M Millar Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness J Health Serv Res Policy 7 2002 111 117
180. T Green, A Savelli Antimicrobial resistance containment strategies of the rational pharmaceutical management program S Knobler S Lemon M Najafi T Burroughs The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment-workshop summary 2003 Institute of Medicine, National Academy of Science Washington DC 215 223
181. HM Richet, J Mohammed, LC McDonald, WR Jarvis Building communication networks: international network for the study and prevention of emerging antimicrobial resistance Emerg Infect Dis 7 2001 319 322